CTOs on the Move

AOR Canada Advanced Orthomolecular Research Inc

www.aor.ca

 
AOR Canada Advanced Orthomolecular Research Inc is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.aor.ca
  • 3900 12 St NE
    Calgary, AB CAN T2E 8H9
  • Phone: 800.387.0177

Executives

Name Title Contact Details

Similar Companies

Talika Beauty

Talika Beauty is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pioneer(R) Surgical Technology, Inc.

Pioneer Surgical is a leading innovator in the design and manufacture of spinal and orthopedic implants and instruments.

Pacific Ambulance

Pacific Ambulance is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Planned Parenthood North Central States

Planned Parenthood North Central States (PPNCS) and its subsidiary organizations provide, promote, and protect reproductive and sexual health through high quality care, education and advocacy. A member of America`s most trusted reproductive health care provider, our affiliate is proud to support and operate 29 health centers across our five-state region (Iowa, Minnesota, Nebraska, North Dakota and South Dakota). Each year, we provide health care to nearly 115,000 people and health education to more than 99,000 people in our region.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.